December 16, 2015
Strongbridge Biopharma plc Announces Presentation at Biotech Showcase 2016
Media
December 11, 2015
Efficacy Results of Melflufen in Combination with Dexamethasone from an Ongoing Open-Label Phase 2 Study in Patients with Relapsed and RelapsedRefractory Multiple Myeloma (RRMM) Presented at ASH
December 10, 2015
HealthCap Investor Seminar
December 10, 2015
BONESUPPORT™ ANNOUNCES RESULTS OF CERAMENT™|BONE VOID FILLER PROSPECTIVE PILOT STUDY DEMONSTRATING COMPLETE BONE REMODELING IN BENIGN BONE TUMORS
December 10, 2015
First patient enters Phase III TANGO clinical trial to evaluate efficacy to regress atherosclerosis and safety of CER-001 in patients with Familial Primary HypoAlphalipoproteinemia (FPHA)
December 10, 2015
HealthCap Investor Seminar
December 09, 2015
New England Journal of Medicine Publishes Groundbreaking Study Demonstrating Benefits of Pulmonx’s Medical Device for Emphysema
December 08, 2015
RSPR Pharma initiates Phase II clinical trial of oral mast cell inhibitor CRD007 in uncontrolled asthma
December 07, 2015
Strongbridge Biopharma Announces Issuance of U.S. Patent for Investigational COR-003 (levoketoconazole) in Treatment of Endogenous Cushing’s Syndrome
December 07, 2015
NORDIC NANOVECTOR PRESENTS PRECLINICAL RESEARCH WITH BETALUTIN® SHOWING POTENTIAL FOR COMBINATION WITH RITUXIMAB IN NON-HODGKIN LYMPHOMA